Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma
Open Access
- 1 November 2003
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 4 (5) , 383-391
- https://doi.org/10.1016/s1535-6108(03)00273-3
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Kallistatin is a new inhibitor of angiogenesis and tumor growthBlood, 2002
- Specialization of tumour vasculatureNature Reviews Cancer, 2002
- A Functional Nuclear Localization Sequence in the C-terminal Domain of SHP-1Journal of Biological Chemistry, 2001
- Peptides Encoded by Exon 6 of VEGF Inhibit Endothelial Cell Biological Responses and Angiogenesis Induced by VEGFBiochemical and Biophysical Research Communications, 2001
- The Expanded Human Kallikrein Gene Family: Locus Characterization and Molecular Cloning of a New Member, KLK-L3 (KLK9)Genomics, 2000
- The Hallmarks of CancerCell, 2000
- Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in MiceScience, 1999
- Host Microvasculature Influence on Tumor Vascular Morphology and Endothelial Gene ExpressionThe American Journal of Pathology, 1998
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Difluoromethylornithine enhances inhibition of melanoma cell growth in soft agar by dexamethasone, clone a interferon and retinoic acidInternational Journal of Cancer, 1986